Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
-
Field
-
possible renewal up to three years. We encourage interested candidates to see the following papers: https://pubs.rsc.org/en/content/articlehtml/2021/ee/d0ee02870c https://pubs.rsc.org/en/content/articlehtml
-
Posting Details Position Details Title Postdoctoral Position: Neuroendocrine Mechanisms of Aggressive Behavior Appointment Status Non-Tenure Track Department IU Bloomington Biology Location
-
) plays a critical role in driving tumor aggressiveness and influencing treatment responses. Key players within this microenvironment are cancer- associated fibroblasts, endothelial cells, immune cells and
-
viral mediated oncogenic transformation in glioblastoma (GBM)—the most common and aggressive primary brain tumor, for which effective therapies are still lacking Duties About the Project Our research has
-
their lifetime. Strikingly, the disease is twice as prevalent in Black men, often presenting earlier and with more aggressive features. Yet, most existing research focuses on white populations, leaving critical
-
strategy (PMIDs: 29123070, 33621493, 33087936, 30566856, 39947938; doi: https://doi.org/10.1101/2025.03.15.641049 ). Postdoctoral Projects Project 1: Replisome Dynamics, Replication Stress, and Cancer
-
aggressive form of brain cancer, characterized by diverse and dynamic cell states that drive treatment resistance and poor prognosis. In this project, funded by the Foundation Against Cancer, you will move
-
Postdoc Appointment Term: 2 year renewable Appointment Start Date: As early as summer 2025 Group or Departmental Website: http://www.staarlab.com (link is external) How to Submit Application Materials
-
Zurich, Basel) and the University Hospital Heidelberg / German Cancer Research Center (Heidelberg, Germany). Project background Glioblastoma (GB) is the most aggressive primary brain cancer in adults
-
common and aggressive primary brain tumor, for which effective therapies are still lacking. Your mission About the Project Our research has shown that approximately 99% of glioblastomas are positive